Search the Newsreel

BlueScope Steel FY26 earnings: Profit and dividends soar

Gilead Sciences (GILD): Buy, Sell, or Hold Post Q2 Earnings?

Gilead Sciences (GILD): Buy, Sell, or Hold Post Q2 Earnings? Over the last six months, Gilead Sciences's shares have sunk to $137.77, producing a disappointing 11.3% loss - a stark contrast to the S&P 500's 13.1% gain. This might have investors contemplating their next …

3 Reasons SCHL is Risky and 1 Stock to Buy Instead

3 Reasons SCHL is Risky and 1 Stock to Buy Instead Scholastic has had an impressive run over the past six months as its shares have beaten the S&P 500 by 9.5%. The stock now trades at $41.58, marking a 22.7% gain. This performance …

Precision Trading with Invesco Electric Vehicle Metals Commodity Strategy No K-1 Etf (EVMT) Risk Zones

This article provides a detailed analysis of Invesco Electric Vehicle Metals Commodity Strategy No K-1 Etf (EVMT), identifying neutral near- and mid-term readings and potential downside risk. It outlines institutional trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis …

ChronoScale Corporation Common Stock (NASDAQ:CHRN) Short Interest Update

Lang & Schwarz Aktie: 14,18 Prozent Minus nach PFOF-Verbot

Pulse Biosciences (PLSE) Stock Looks Pricey On Book Value Yet Strong On Returns

Scholastic director Kaya Henderson sells $130,812 in stock

Scholastic Corp. director Kaya Henderson sold 3,250 shares of company stock for $130,812 on August 6, 2026. Following the sale, Henderson beneficially owns 7,113 shares. The transaction occurred amidst Scholastic reporting Q4 earnings that met profit forecasts but missed revenue expectations, with the stock …

Banco Bilbao Vizcaya Argentaria (BME:BBVA) Draws Options Attention, Is The Stock Fully Valued?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Banco Bilbao Vizcaya Argentaria (BME:BBVA) is drawing fresh attention after the September 18, 2026 €25.00 call option showed some of the highest implied …

Ascendis Pharma A/S Just Recorded A 104% EPS Beat: Here's What Analysts Are Forecasting Next

Ascendis Pharma A/S reported strong Q2 results, with revenues beating expectations by 2.8% and statutory profit exceeding forecasts by 104%. Analysts have subsequently upgraded their EPS estimates for 2026, though the consensus price target remains unchanged at US$310. The company is expected to continue …

Oscar Health (OSCR) Is Up 17.4% After Swinging To Profit And Raising 2026 Guidance - What's Changed

Die Gilead-Sciences-Aktie steigt nach starken Q2-Zahlen und Anlegerzuflüssen

Die Edwards-Lifesciences-Aktie steigt nach starken Quartalszahlen und optimistischer Prognose

How Henry Schein’s Strong Q2 Earnings and Higher 2026 Sales Outlook Will Impact Henry Schein (HSIC) Investors

Henry Schein, Inc. reported strong Q2 2026 earnings with increased sales and net income, leading management to raise its full-year 2026 sales growth guidance to 4.5% to 5.5%. This positive outlook reinforces the company's strategy of shifting towards higher-margin technology and specialty products, despite …

9,961 Shares in Cisco Systems, Inc. $CSCO Purchased by TFR Capital LLC.

TFR Capital LLC purchased 9,961 shares of Cisco Systems, Inc. valued at approximately $1.17 million in the second quarter. This comes as Cisco reported strong Q4 results with revenue up 17.6% year-over-year, driven by a significant increase in AI infrastructure orders, although concerns remain …

(PLSE) Risk Channels and Responsive Allocation

This article provides an in-depth AI-driven analysis for Pulse Biosciences Inc (NASDAQ: PLSE), highlighting strong sentiment across all horizons and compelling upside potential. It details institutional trading strategies with specific entry zones, targets, and stop losses for position trading, momentum breakout, and risk hedging. …

Warner Bros. Discovery Stock 8-Day Winning Spree: Stock Climbs 8.5%

Will Gilead’s AI-Driven ADC Research with Nucleai Refine Its Oncology Strategy and Valuation Story (GILD)?

Gilead Sciences is partnering with Nucleai for AI-powered tissue analytics to enhance its antibody-drug conjugate (ADC) clinical development and precision oncology efforts. This collaboration supports Gilead's long-term strategy to pivot into oncology, leveraging its strong HIV core business. However, despite the potential of AI-enabled …

Die Boston-Scientific-Aktie stabilisiert sich nach starken Quartalszahlen

Oppenheimer Asset Management Inc. Makes New Investment in SiteOne Landscape Supply, Inc. $SITE

Oppenheimer Asset Management Inc. has acquired a new position in SiteOne Landscape Supply, Inc. (NYSE:SITE), purchasing 26,740 shares valued at approximately $3.06 million. This investment comes amidst mixed analyst sentiment, with a consensus "Hold" rating despite the company missing recent quarterly earnings and revenue …

Summit Global Investments Buys New Shares in Gilead Sciences, Inc. $GILD

Summit Global Investments initiated a new position in Gilead Sciences, acquiring 11,712 shares valued at $1.48 million during the second quarter. Gilead Sciences reported strong Q2 earnings, surpassing revenue and EPS expectations, with a 10.6% year-over-year revenue increase and declared a quarterly dividend of …

Simplify Asset Management Inc. Buys 5,670 Shares of Thermo Fisher Scientific Inc. $TMO

Simplify Asset Management Inc. increased its stake in Thermo Fisher Scientific Inc. (TMO) by 32.6% in the second quarter, purchasing 5,670 additional shares. This brings their total holding to 23,079 shares, valued at approximately $11.6 million. Institutional investors collectively own 89.23% of TMO, with …

Union Bancaire Privee UBP SA Grows Stock Holdings in Thermo Fisher Scientific Inc. $TMO

HM Payson & Co. Sells 20,885 Shares of Thermo Fisher Scientific Inc. $TMO

HM Payson & Co. reduced its stake in Thermo Fisher Scientific Inc. by 11.3%, selling 20,885 shares but still holding 163,790 shares valued at $82.1 million. Despite insider selling of over $30.6 million in the last 90 days, Thermo Fisher reported strong quarterly results …

Is Alto Neuroscience (ANRO) Fully Valued As ALTO 207 Expands With New Funding?

Warner Bros. Discovery (WBD) After Q2 Streaming Strength Raises Fresh Fair Value Questions

Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside (NYSE:TMO)

Thermo Fisher Scientific Inc. $TMO Shares Sold by Wedge Capital Management L L P NC

Wedge Capital Management L L P NC significantly reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 93.3% in the second quarter, selling over 11,000 shares. Despite this, other institutional investors either increased or initiated stakes in the company, with institutional ownership remaining …

Centric Wealth Management Takes $3.52 Million Position in Gilead Sciences, Inc. $GILD

Centric Wealth Management has acquired a new stake of 26,506 shares in Gilead Sciences, Inc. (NASDAQ:GILD), valued at approximately $3.52 million during the second quarter. This move is part of broader institutional interest, with 83.67% of Gilead's stock owned by institutional investors and hedge …

Crescent Energy Company $CRGY Stock Holdings Lifted by NewEdge Advisors LLC

GSA Capital Partners LLP Acquires New Position in MSCI Inc $MSCI

GSA Capital Partners LLP has acquired a new position in MSCI Inc. (NYSE:MSCI), purchasing 3,826 shares valued at approximately $2.143 million during the second quarter. This move comes as other institutional investors have also adjusted their stakes in the technology company. MSCI recently announced …

Quantinno Capital Management LP Purchases 36,144 Shares of Castle Biosciences, Inc. $CSTL

Quantinno Capital Management LP significantly increased its stake in Castle Biosciences, Inc. (NASDAQ:CSTL) by 387.3% in the first quarter, acquiring an additional 36,144 shares. This brings their total holdings to 45,476 shares, valued at approximately $1.12 million. While institutional investors own a large portion …

DO & CO Aktiengesellschaft (VIE:DOC) hat soeben die Ergebnisse des ersten Quartals veröffentlicht: Das prognostizieren Analysten für dieses Jahr

Focus Partners Advisor Solutions LLC Purchases New Stake in Cisco Systems, Inc. $CSCO

Focus Partners Advisor Solutions LLC has acquired a new stake in Cisco Systems, Inc. (NASDAQ:CSCO), purchasing 104,857 shares valued at approximately $12.3 million during the second quarter. This move comes as several other institutional investors have also adjusted their holdings in Cisco, with the …

Clearstead Trust LLC Purchases New Holdings in Cisco Systems, Inc. $CSCO

Clearstead Trust LLC recently acquired 22,287 shares of Cisco Systems (CSCO) valued at approximately $2.6 million in the second quarter. This move comes as Cisco reported strong quarterly results, surpassing analyst expectations with $1.22 EPS and $17.25 billion in revenue, driven by accelerating AI …

Family Legacy Inc. Invests $3.83 Million in Cisco Systems, Inc. $CSCO

Family Legacy Inc. recently invested $3.83 million in Cisco Systems, Inc. by purchasing 32,613 shares during the second quarter. This comes as Cisco exceeded quarterly expectations with $1.22 EPS and $17.25 billion in revenue, representing 17.6% year-over-year growth. Despite a "Moderate Buy" consensus from …